Gossamer Bio Inc (NAS:GOSS)
$ 0.7033 -0.0267 (-3.66%) Market Cap: 159.10 Mil Enterprise Value: 129.80 Mil PE Ratio: 0 PB Ratio: 5.86 GF Score: 37/100

Q2 2021 Gossamer Bio Inc Earnings Call Transcript

Aug 09, 2021 / 08:30PM GMT
Release Date Price: $8.36 (+1.33%)
Operator

Good day, and thank you for standing by. Welcome to the Gossamer Bio Q2 Earnings Call. (Operator Instructions)

And I would now like to turn the call over to your first speaker, Bryan Giraudo, Chief Financial Officer. You may begin your conference.

Bryan Giraudo
Gossamer Bio, Inc. - CFO

Thank you, operator, and thank you all for joining us this afternoon. I'm joined on today's call by Gossamer Bio's Chairman, Co-Founder and Chief Executive Officer, Faheem Hasnain; Richard Aranda, Gossamer Bio's Chief Medical Officer; as well as Laura Carter, Gossamer Bio's Chief Scientific Officer.

Earlier this afternoon, Gossamer Bio issued a press release announcing its financial results for the second quarter ended June 30, 2021, in addition to providing a corporate update.

Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements. Actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot